Mps Sawhney1, Y K Sharma2. 1. Senior Advisor (Derm & Ven), Base Hosp, Delhi Cantt. 2. Commandant, Command Hospital, Northern Command, C/o 56 APO.
Abstract
BACKGROUND: Tuberculin skin testing (TST) is a reliable tool in the diagnosis of tuberculous infection and is important in its control. However, it may be false negative in immunocompromised patients like HIV-infected. METHODS: We examined the pattern of TST results in 523 newly diagnosed HIV-positive patients. CD4, CD8 and absolute lymphocyte counts were done by flowcytometry in 63 of these cases. RESULTS: 56 (44.10%), 15 (11.81%) and 56 (44.10%) of the 127 cases with tuberculosis and 293 (73.99%), 41 (10.35%) and 62 (15.66%) of the 396 cases without any clinical evidence of tuberculosis showed TST results of 0-4, 5-9 and = or > 10 mm respectively. Significantly more (P<0.05) number of cases with TST of = or > 10mm and significantly lesser (P<0.05) number of cases with TST of 0-4 mm are likely to develop tuberculosis. The average CD4+lymphocyte count was found to be significantly lower in cases with nil TST results than with = or >10mm. HIV infected cases associated with tuberculosis with induration on TST had average CD4 counts of 129.5 as compared to 246.3/cmm in those without tuberculosis. CONCLUSION: In India where both these diseases are endemic, tuberculosis may develop during early HIV infection, while the body's immunity is still largely unimpaired and TST shows = or >10mm results in almost 45% of our cases. In another 45% with TST of 0-4mm, the CD4+ lymphocyte count is likely to be lower than 200/cmm. In those with nil induration, TST of 5-9 mm cannot be taken as an independent marker for suspecting tuberculosis in the HIV infected. Hence we recommend that all cases with TST of = or >10mm and cases with nil induratrion with CD4+ count of <200/cmm should be considered as high-risk for developing tuberculosis.
BACKGROUND: Tuberculin skin testing (TST) is a reliable tool in the diagnosis of tuberculous infection and is important in its control. However, it may be false negative in immunocompromised patients like HIV-infected. METHODS: We examined the pattern of TST results in 523 newly diagnosed HIV-positivepatients. CD4, CD8 and absolute lymphocyte counts were done by flowcytometry in 63 of these cases. RESULTS: 56 (44.10%), 15 (11.81%) and 56 (44.10%) of the 127 cases with tuberculosis and 293 (73.99%), 41 (10.35%) and 62 (15.66%) of the 396 cases without any clinical evidence of tuberculosis showed TST results of 0-4, 5-9 and = or > 10 mm respectively. Significantly more (P<0.05) number of cases with TST of = or > 10mm and significantly lesser (P<0.05) number of cases with TST of 0-4 mm are likely to develop tuberculosis. The average CD4+lymphocyte count was found to be significantly lower in cases with nil TST results than with = or >10mm. HIV infected cases associated with tuberculosis with induration on TST had average CD4 counts of 129.5 as compared to 246.3/cmm in those without tuberculosis. CONCLUSION: In India where both these diseases are endemic, tuberculosis may develop during early HIV infection, while the body's immunity is still largely unimpaired and TST shows = or >10mm results in almost 45% of our cases. In another 45% with TST of 0-4mm, the CD4+ lymphocyte count is likely to be lower than 200/cmm. In those with nil induration, TST of 5-9 mm cannot be taken as an independent marker for suspecting tuberculosis in the HIV infected. Hence we recommend that all cases with TST of = or >10mm and cases with nil induratrion with CD4+ count of <200/cmm should be considered as high-risk for developing tuberculosis.
Authors: José J Portu; Mikel Aldamiz-Etxebarria; José M Agud; José M Arévalo; María J Almaraz; Cándido Ayensa Journal: Addict Biol Date: 2002-04 Impact factor: 4.280
Authors: H Yanai; W Uthaivoravit; T D Mastro; K Limpakarnjanarat; P Sawanpanyalert; R H Morrow; P Nieburg Journal: Int J Tuberc Lung Dis Date: 1997-10 Impact factor: 2.373
Authors: A Kaur; P G Babu; M Jacob; C Narasimhan; A Ganesh; N K Saraswathi; D Mathai; B M Pulimood; T J John Journal: J Acquir Immune Defic Syndr (1988) Date: 1992
Authors: N Kumarasamy; Suniti Solomon; Timothy P Flanigan; R Hemalatha; S P Thyagarajan; Kenneth H Mayer Journal: Clin Infect Dis Date: 2002-12-09 Impact factor: 9.079
Authors: L E Duncan; A M Elliott; R J Hayes; S K Hira; G Tembo; G T Mumba; S H Ebrahim; M Quigley; J O Pobee; K P McAdam Journal: Trans R Soc Trop Med Hyg Date: 1995 Jan-Feb Impact factor: 2.184